{"id":"W4402348974","doi":"10.1093/bjd/ljae342","title":"A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Innovaderm (Canada)","funders":"Eli Lilly Japan; Sanofi Genzyme; Otsuka Pharmaceutical; Genentech; National Jewish Health; Torii Pharmaceutical; Kiniksa Pharmaceuticals; Taiho Pharmaceutical; Kyowa Kirin Pharmaceutical Development; Castle Biosciences; Celgene; BioCryst; Sun Pharma; Dermira; Valeant Pharmaceuticals International; Pfizer; Incyte; Regeneron Pharmaceuticals; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; LEO Pharma; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen","keywords":"Medicine; Atopic dermatitis; Dosing; Pharmacovigilance; Omalizumab; Adverse effect; MEDLINE; Expert opinion; Clinical trial; Intensive care medicine; Internal medicine; Dermatology; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006693685,0.001280897,0.001458514,0.003864398,0.00145446,0.004372544,0.001985598,0.005795618,0.0795322],"category_scores_gemma":[0.03006421,0.0008619587,0.001525839,0.002284463,0.001020727,0.004342951,0.002459751,0.006694887,0.08524445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001155354,"about_ca_system_score_gemma":0.005489152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002157944,"about_ca_topic_score_gemma":0.006235293,"domain_scores_codex":[0.9933264,0.002436833,0.001406863,0.0004040853,0.002137539,0.0002882487],"domain_scores_gemma":[0.9799697,0.006049777,0.001776665,0.0008521641,0.008849817,0.002501952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002666199,0.00005907791,0.0001223273,0.0003827319,0.000004777538,0.0002407432,0.000186454,0.00002917201,0.0002839566,0.0006485371,0.8926269,0.1053886],"study_design_scores_gemma":[0.00002315236,0.00004327143,0.0002679602,0.0008123303,0.000005402023,0.0006147433,0.0001412946,0.00003240311,0.0000602099,0.0007956959,0.9971902,0.00001336083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.002230906,0.129072,0.04799482,0.4427665,0.07480811,0.003956194,0.005457337,0.008571791,0.2851424],"genre_scores_gemma":[0.01034605,0.1497729,0.1683425,0.2701658,0.03793538,0.00557915,0.006498965,0.002721681,0.3486376],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.0795322,"threshold_uncertainty_score":0.2660617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05098543487854836,"score_gpt":0.3448604056599803,"score_spread":0.293874970781432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}